Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy
Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy
Recruiting · NCT06276088 · Registry updated 2024-03-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy | Biomarker; Hyperprogression; Immunotherapy | Recruiting | Not stated | 2024-03-15 | NCT06276088 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nanfang Hospital, Southern Medical University | 248 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fujian Provinical Hospital | Fuzhou | China | 2 |
| Huizhou Central People's Hospital | Huizhou | China | 5 |
| Jieyang People's Hospital | Jieyang | China | 3 |
| Meizhou People's Hospital, Meizhou Academy of Medical Sciences Meizhou | Meizhou | China | 2 |
| Nanfang Hospital, Southern Medical University | Guangzhou | China | 83 |